An aggressive gastric CIC-DUX4 sarcoma surgically resected with multivisceral organs: a case report.

CIC-DUX4 sarcoma Stomach Surgical resection

Journal

Surgical case reports
ISSN: 2198-7793
Titre abrégé: Surg Case Rep
Pays: Germany
ID NLM: 101662125

Informations de publication

Date de publication:
23 Oct 2024
Historique:
received: 25 07 2024
accepted: 30 09 2024
medline: 23 10 2024
pubmed: 23 10 2024
entrez: 23 10 2024
Statut: epublish

Résumé

Capicua transcriptional repressor-double homeobox 4 sarcoma (CDS) is a rare and aggressive malignant soft tissue tumor that typically arises within the soft tissues. We report an exceptionally rare case of a gastric CDS successfully resected despite its extensive invasion into surrounding organs. A 48-year-old male presented with a progressively enlarging abdominal mass. Upper gastrointestinal endoscopy revealed a large ulcerative tumor on the posterior gastric wall. Biopsy results initially suggested a neuroendocrine cell carcinoma. Contrast-enhanced computed tomography showed a 20 cm tumor protruding from the posterior stomach wall, directly invading the pancreas and colon. We performed a multivisceral resection (stomach, pancreatic tail, spleen, and transverse colon) achieving an R0 resection. Pathological examination of the permanent specimen revealed small round cells with high nuclear-to-cytoplasmic ratios. Immunohistochemical staining confirmed the diagnosis of CDS. The patient recovered well and was discharged on postoperative day 33. This case report describes the first detailed account of a surgically resected aggressive CDS originating from the stomach.

Sections du résumé

BACKGROUND BACKGROUND
Capicua transcriptional repressor-double homeobox 4 sarcoma (CDS) is a rare and aggressive malignant soft tissue tumor that typically arises within the soft tissues. We report an exceptionally rare case of a gastric CDS successfully resected despite its extensive invasion into surrounding organs.
CASE PRESENTATION METHODS
A 48-year-old male presented with a progressively enlarging abdominal mass. Upper gastrointestinal endoscopy revealed a large ulcerative tumor on the posterior gastric wall. Biopsy results initially suggested a neuroendocrine cell carcinoma. Contrast-enhanced computed tomography showed a 20 cm tumor protruding from the posterior stomach wall, directly invading the pancreas and colon. We performed a multivisceral resection (stomach, pancreatic tail, spleen, and transverse colon) achieving an R0 resection. Pathological examination of the permanent specimen revealed small round cells with high nuclear-to-cytoplasmic ratios. Immunohistochemical staining confirmed the diagnosis of CDS. The patient recovered well and was discharged on postoperative day 33.
CONCLUSIONS CONCLUSIONS
This case report describes the first detailed account of a surgically resected aggressive CDS originating from the stomach.

Identifiants

pubmed: 39441368
doi: 10.1186/s40792-024-02035-0
pii: 10.1186/s40792-024-02035-0
doi:

Types de publication

Journal Article

Langues

eng

Pagination

241

Informations de copyright

© 2024. The Author(s).

Références

World Health Organization. Soft tissue and bone tumors WHO classification of tumors. 5th ed. Lyon: WHO; 2020.
Antonescu CR, Owosho AA, Zhang L, Chen S, Deniz K, Huryn JM, et al. Sarcomas with CIC-rearrangements are a distinct pathologic entity with aggressive outcome: a clinicopathologic and molecular study of 115 cases. Am J Surg Pathol. 2017;41(7):941–9. https://doi.org/10.1097/PAS.0000000000000846 .
doi: 10.1097/PAS.0000000000000846 pubmed: 28346326 pmcid: 5468475
Connolly EA, Bhadri VA, Wake J, Ingley KM, Lewin J, Bae S, et al. Systemic treatments and outcomes in CIC-rearranged sarcoma: a national multi-centre clinicopathological series and literature review. Cancer Med. 2022;11(8):1805–16. https://doi.org/10.1002/cam4.4580 .
doi: 10.1002/cam4.4580 pubmed: 35178869 pmcid: 9041083
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13. https://doi.org/10.1097/01.sla.0000133083.54934.ae .
doi: 10.1097/01.sla.0000133083.54934.ae pubmed: 15273542 pmcid: 1360123
Yoshida A, Goto K, Kodaira M, Kobayashi E, Kawamoto H, Mori T, et al. CIC-rearranged sarcomas: a study of 20 cases and comparisons with Ewing sarcomas. Am J Surg Pathol. 2016;40(3):313–23. https://doi.org/10.1097/PAS.0000000000000570 .
doi: 10.1097/PAS.0000000000000570 pubmed: 26685084
Specht K, Sung YS, Zhang L, Richter G, Fletcher CD, Antonescu CR. Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion–positive round cell tumors compared to EWSR1-rearranged ewing sarcomas: further evidence toward distinct pathologic entities. Genes Chromosomes Cancer. 2014;53:622–33. https://doi.org/10.1002/gcc.22172 .
doi: 10.1002/gcc.22172 pubmed: 24723486 pmcid: 4108073
Siegele B, Roberts J, Black JO, Rudzinski E, Vargas SO, Galambos C. DUX4 immunohistochemistry is a highly sensitive and specific marker for CIC-DUX4 fusion-positive round cell tumor. Am J Surg Pathol. 2017;41(3):423–9. https://doi.org/10.1097/PAS.0000000000000772 .
doi: 10.1097/PAS.0000000000000772 pubmed: 27879517
Le Guellec S, Velasco V, Pérot G, Watson S, Tirode F, Coindre JM. ETV4 is a useful marker for the diagnosis of CIC-rearranged undifferentiated round-cell sarcomas: a study of 127 cases including mimicking lesions. Mod Pathol. 2016;29(12):1523–31. https://doi.org/10.1038/modpathol.2016.155 .
doi: 10.1038/modpathol.2016.155 pubmed: 27562494
Racanelli D, Brenca M, Baldazzi D, Goeman F, Casini B, De Angelis B, et al. Next-generation sequencing approaches for the identification of pathognomonic fusion transcripts in sarcomas: the experience of the Italian ACC sarcoma working group. Front Oncol. 2020;15(10):489. https://doi.org/10.3389/fonc.2020.00489 .
doi: 10.3389/fonc.2020.00489
Wu Q, He Y. A case report of CIC-DUX4 fusion-positive sarcoma in the pelvic cavity with targeted next-generation sequencing results. Front Oncol. 2022;15(12):1018992. https://doi.org/10.3389/fonc.2022.1018992 .
doi: 10.3389/fonc.2022.1018992
Mancarella C, Carrabotta M, Toracchio L, Scotlandi K. CIC-rearranged sarcomas: an intriguing entity that may lead the way to the comprehension of more common cancers. Cancers. 2022;14(21):5411. https://doi.org/10.3390/cancers14215411 .
doi: 10.3390/cancers14215411 pubmed: 36358827 pmcid: 9657047

Auteurs

Mizuki Koba (M)

Department of Surgery, NHO Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan.

Atsushi Takeno (A)

Department of Surgery, NHO Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan. atakeno1008@me.com.

Hiroko Hasegawa (H)

Department of Gastroenterology and Hepatology, NHO Osaka National Hospital, Osaka, Japan.

Ryotaro Sakamori (R)

Department of Gastroenterology and Hepatology, NHO Osaka National Hospital, Osaka, Japan.

Rei Higashiura (R)

Department of Gastroenterology and Hepatology, NHO Osaka National Hospital, Osaka, Japan.

Masaaki Yamamoto (M)

Department of Surgery, NHO Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan.

Shinji Tokuyama (S)

Department of Surgery, NHO Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan.

Reishi Toshiyama (R)

Department of Surgery, NHO Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan.

Kenji Kawai (K)

Department of Surgery, NHO Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan.

Yusuke Takahashi (Y)

Department of Surgery, NHO Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan.

Kenji Sakai (K)

Department of Surgery, NHO Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan.

Naoki Hama (N)

Department of Surgery, NHO Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan.

Kunihito Gotoh (K)

Department of Surgery, NHO Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan.

Takeshi Kato (T)

Department of Surgery, NHO Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan.

Yumiko Hirose (Y)

Department of Central Laboratory and Surgical Pathology, NHO Osaka National Hospital, Osaka, Japan.

Kiyoshi Mori (K)

Department of Central Laboratory and Surgical Pathology, NHO Osaka National Hospital, Osaka, Japan.

Masayuki Mano (M)

Department of Central Laboratory and Surgical Pathology, NHO Osaka National Hospital, Osaka, Japan.

Motohiro Hirao (M)

Department of Surgery, NHO Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan.

Classifications MeSH